Evaluation of the effect of jujube product on Covid-19 patients

INTERVENTION: Intervention 1: Intervention group: In addition to the treatment protocol, patients receive 7 cc of jujube twice a day, 7 cc each. Intervention 2: Control group: The treatment is done according to the protocol and is only for comparison with the intervention group. CONDITION: B34.2 COVID‐19. ; Coronavirus infection, unspecified PRIMARY OUTCOME: Clinical symptoms (Coronavirus infection). Timepoint: Before starting the study and daily until discharge. Method of measurement: Laboratory values and radiographic changes or CT scans and questionnaire. INCLUSION CRITERIA: The patient does not suffer from any serious concomitant diseases of the pulmonary, cerebral, and endocrine glands The patient's ability and personal desire to fill out a personal consent form to enter the study The patient has not been intubated